Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$LBRG Ladybug Announces Acquisition of E-Commerce Generating $2.4 Million Annual Revenue
https://finance.yahoo.com/news/ladybug-announces-acquisition-e-commerce-121500825.html
$SYNX Silynx provides protection for our canine warriors.
Silynx provides protection for our canine warriors. $SYNX #k9hearingprotection #fourleggedwarriors #bestinclass 🐾🐾 pic.twitter.com/meaZrNBirX
— Silynx Communications (@silynxcomm) March 5, 2024
$$$???»»»STRC«««???$$$
THE NEXT HUGE WINNER!
$NRXP News: NRx Pharmaceuticals (NASDAQ: NRXP) Announces Last Patient, Last Visit in its Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression
Marks a major step in the development of what could be the first drug approved for Suicidal Bipolar Depression
The study database is being cleaned and locked; statistical analysis and top-line data to follow shortly thereafter
Study maintained 95% concordance rate between study sites and central raters on primary endpoint. No unexpected Serious Adverse Events were reported.
Positive data and FDA comment would trigger the next $4 million milestone payment from partners Alvogen and Lotus and their assumption of development costs; agreement provides for up to $329 million in milestone payments and a royalty on Net Sales in the mid-teens
RADNOR, Pa., March 4, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that the 74th and last evaluable patient has completed their day 42 visit in its Phase 2b/3 study of NRX-101, the Company's patented combination of the NMDA antagonist D-cycloserine and lurasidone, in Suicidal Treatment Resistant Bipolar Depression. The database is being cleaned, finalized, and locked; statistical analysis will then be performed, with top-line data to follow shortly thereafter. As previously disclosed, positive data from this trial triggers a milestone payment from Alvogen. Alvogen will then be responsible for further development and commercialization costs for this program.
NRX-101 has been awarded Breakthrough Therapy Designation, Fast Track Designation, a Biomarker Letter of Support, and a Special Protocol Agreement by the FDA for treatment of suicidal bipolar depression. It is the only oral medication to have demonstrated reduced suicidal ideation in patients with bipolar depression, a lethal disease that claims the lives of one in five who live with it.
"This is the first clinical trial, to the company's knowledge, conducted among patients with suicidal bipolar depression in the outpatient setting. Our previous trial measured the ability of NRX-101 to maintain the anti-depressant and anti-suicidal effect of ketamine administered in the hospital setting. These patients, whose clinical need is urgent and extraordinary have routinely been excluded from the clinical trials of all previously-known anti-depressant drugs. said Dr. Jonathan Javitt, Founder, Chairman and Chief Scientist of NRx Pharmaceuticals. Although there were patients whose depression worsened and required hospitalization (we don't yet know whether they were on NRX-101 or comparator), patient safety was maintained, and no trial participant suffered a serious unexpected adverse outcome. Our thanks go out to our investigators, clinics, partners and, most importantly, our amazing patients and their families for seeing this study through to this important milestone," "
The Phase 2b/3 trial (www.clinicaltrials.gov NCT 03395392) is a randomized, prospective, multicenter, double-blind study comparing NRX-101 to lurasidone over six weeks. The Principal Investigator is Prof. Andrew Nierenberg of Harvard Massachusetts General Hospital. The primary efficacy endpoint is reduction in depression as measured on the MADRS scale and the secondary endpoint is reduction of suicidal ideation as measured by the Clinical Global Impression Suicidality Scale (CGI-SS). As previously disclosed, treatment compliance and concordance of local raters to central raters scores was in excess of 94%, well above the industry standard that is normally seen in CNS trials.
Top-line results are expected around the end of this quarter.
About NRx Pharmaceuticals
NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain and PTSD. The Company is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRx has partnered with Alvogen and Lotus around the development and marketing of NRX-101 for the treatment of suicidal bipolar depression. NRX-101 additionally has potential to act as a non-opioid treatment for chronic pain, as well as a treatment for complicated UTI.
NRx has recently announced plans to submit a New Drug Application for HTX-100 (IV ketamine), through Hope Therapeutics, in the treatment of suicidal depression, based on results of well-controlled clinical trials conducted under the auspices of the US National Institutes of Health and newly obtained data from French health authorities, licensed under a data sharing agreement. NRx was awarded Fast Track Designation for development of ketamine (NRX-100) by the US FDA as part of a protocol to treat patients with acute suicidality.
About HOPE Therapeutics, Inc.
HOPE Therapeutics, Inc. (www.hopetherapeutics.com) is a Specialty Pharmaceutical Company, wholly-owned by NRX Pharmaceuticals focused on development and marketing of an FDA-approved form of intravenous ketamine for the treatment of acute suicidality and depression together with a digital therapeutic-enabled platform designed to augment and preserve the clinical benefit of NMDA-targeted drug therapy.
Notice Regarding Forward-Looking Statements
The information contained herein includes forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. These statements include, among others, statements regarding the proposed public offering and the timing and the use of the proceeds from the offering. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to the Company's operations, results of operations, growth strategy and liquidity. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's most recent Annual Report on Form 10-K and other filings with the Securities and Exchange Commission. Investors and security holders are urged to read these documents free of charge on the SEC's website at http://www.sec.gov. Except as may be required by applicable law, The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, whether as a result of new information, future events or otherwise.
https://c212.net/c/img/favicon.png?sn=CL51263&sd=2024-03-04 View original content to download multimedia:https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-nasdaq-nrxp-announces-last-patient-last-visit-in-its-phase-2b3-trial-of-nrx-101-in-suicidal-treatment-resistant-bipolar-depression-302078041.html
SOURCE NRx Pharmaceuticals, Inc.
$DFCO Dalrada CEO's Plan to Dominate the Global Heat Pump Market
PRESS RELEASE $CBDW 1606 Corp
*** PRESS RELEASE *** 1606 Corp. Announces AI ChatBot Product Development for Financial Industry | SEATTLE, WA / ACCESSWIRE / March 5, 2024 / 1606 Corp. (OTC PINK: $CBDW) (the "Company"), in a strategic move to revolutionize customer engagement and expand its market reach, 1606… pic.twitter.com/UmaPF3oZYi
— CBDW.ai | A Brand by 1606 Corp (@CBDWInc) March 5, 2024
Silynxcom $SYNX Unveils Dual-Use Headset for Military Dogs https://reddit.com/r/stockstobuytoday/comments/1b75m1g/silynxcom_synx_unveils_dualuse_headset_for/
#BreakingNews: $LBRG Ladybug Announces Acquisition of E-Commerce Generating $2.4 Million Annual Revenue
https://finance.yahoo.com/news/ladybug-announces-acquisition-e-commerce-121500825.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr
$LBRG the parent company of Growhouse Nutraceuticals, is pleased to announce its strategic rebranding as Ladybug NutraTech. https://finance.yahoo.com/news/ladybug-group-inc-rebrands-ladybug-121500618.html
$SYNX Silynxcom Received $550,000 in Orders from Israel Defense and Israeli Police Forces Since Beginning of Year https://finance.yahoo.com/news/silynxcom-received-550-000-orders-142800035.html
Best Growth Stocks Takes a Deep Dive into Potential Fisker Nissan Deal - https://www.nasdaq.com/press-release/bestgrowthstocks.com-takes-a-deep-dive-into-potential-fisker-nissan-deal-2024-03-03
$LBRG is delighted to announce that Bilal Bhamji has joined our company as Chief Financial Officer (CFO), and James Kurko has come on board as a Director. https://finance.yahoo.com/news/ladybug-group-inc-announces-addition-121500907.html
Filing Delayed, but Potential High! 🚀$EDXC may be ready to bounce back! 📈🚀 Keep an eye on this sleeper! 💎
https://finance.yahoo.com/news/endexx-corporation-announces-transition-auditor-140000342.html
$CBDW 1606 Corp. Recaps Major Accomplishments in February & Provides Outlook For March https://finance.yahoo.com/news/1606-corp-recaps-major-accomplishments-133000801.html
$TWOH Two Hands Group stands at the forefront of transforming the food distribution landscape in Canada by leveraging a meticulously crafted playbook for acquiring food merchants with revenues between $1.5M and 5 million dollars. https://twohandsgroup.com/blog/strategic-expansion-twoh-acquisition-playbook
$SYNX SILYNXCOM DELIVERS $280,000 REPEAT ORDER FROM MILITARY CUSTOMER
https://fragoutmag.com/silynxcom-delivers-280000-repeat-order-from-military-customer/
$TWOH Two Hands Corporation Launches Sports Illustrated Line Protein Bars in Canada https://finance.yahoo.com/news/two-hands-corporation-launches-sports-155000347.html
Revolutionizing Canine Warfare: $SYNX Silynxcom's Innovative Headset for Military Dogs
https://bnnbreaking.com/conflict-defence/military/revolutionizing-canine-warfare-silynxcoms-innovative-headset-for-military-dogs
Trifecta of Sales and Marketing Excellence at $CBDW 1606 Corp!
https://cbdw.ai/trifecta-of-sales-and-marketing-excellence-at-1606-corp/
$SYNX Silynxcom Received $550,000 in Orders from Israel Defense Forces and Israeli Police Forces Since Beginning of Year https://finance.yahoo.com/news/silynxcom-received-550-000-orders-142800035.html
$SYNX : Elevate Your Hunting Experience - Silynx's shooting and hunting configurations ensure you're always connected, with superhuman hearing better focused on the hunt.
Elevate Your Hunting Experience - Silynx's shooting and hunting configurations ensure you're always connected, with superhuman hearing better focused on the hunt. #HuntingCommunications #SilynxHunting $SYNX pic.twitter.com/zzntepXQXD
— Silynx Communications (@silynxcomm) February 29, 2024
1606 Corp. (OTC: $CBDW): Revolutionizing CBD Customer Service with AI Innovation
Silynxcom $SYNX Receives $400,000 Follow Up Order from a Leading Global Defense Company https://www.reddit.com/r/SmallCapGrowth/comments/1b31hj6/silynxcom_synx_receives_400000_follow_up_order/
$CBDW — Future-Proof Your Business: Will you Embrace ChatBots & AI or Risk Falling Behind in the Digital Revolution https://cbdw.ai/future-proof-your-business-will-you-embrace-chatbots-ai-or-risk-falling-behind-in-the-digital-revolution/
1606 Corp. $CBDW Recaps Major Accomplishments in February & Provides Outlook For March
https://www.reddit.com/r/Shortsqueeze/comments/1b2zt92/1606_corp_cbdw_recaps_major_accomplishments_in/
$SYNX Silynxcom Delivers $280,000 Repeat Order from Military Customer https://finance.yahoo.com/news/silynxcom-delivers-280-000-repeat-133000151.html
If your looking for breakouts HERB APRU LSEB are good ones with good share structure and catalysts. also IGPK but that one is a little riskier
$TWOH TWO HANDS GROUP: REDEFINING WHOLESALE FOOD DISTRIBUTION THROUGH INNOVATION AND STRATEGIC ACQUISITIONS, A GROWTH STOCK TO WATCH. https://twohandsgroup.com/blog/twoh-strategic-acquisition-growth-stock-to-watch
$CBDW 1606 Corp Discover AI-driven conversational e-commerce for online retailers
$GEVI Mighty Fire Breaker and 42 patents. Great share structure and volume picking up. Pay attention to this one!
$CBDW -- 1606 Corp's Partnership with Cannasite Sparks Rapid Revenue Growth for CBDW's AI-Driven Chatbot
$CBDW 1606 Corp CEO @ CES Making Deals!
$AGBA CELEBRATES MAJOR MILESTONE WITH SUCCESSFUL COMPLETION OF PRIVATE PLACEMENT AT A PREMIUM TO MARKET PRICE https://www.agba.com/company/newsroom/media-release/agba-celebrates-major-milestone-with-successful-completion-of-private-placement-at-a-premium-to-market-price/
$TWOH Two Hands Corporation Launches Sports Illustrated Line Protein Bars in Canada https://finance.yahoo.com/news/two-hands-corporation-launches-sports-155000347.html
Mr. Wing-Fai Ng, Group President, $AGBA Group Holding Limited said “The successful completion of our private placement is an accomplishment that speaks volumes about the strength and potential of our business. The infusion of new capital at this opportune moment will put us in a supreme position to capture growth that we now see coming in 2024.” https://finance.yahoo.com/news/agba-celebrates-major-milestone-successful-140000317.html
$SYNX Silynx videos are meant to inform our brave,
hardcore users on the best practices in using our
gear in the field. Our mission is to keep you safe
and connected as you do the hard work on the front
lines for the rest of us.
https://www.silynxcom.com/our-videos/
$NICH is finally ready to produce and start bottling with Alamo Distillery.
After extensive interviews with multiple nationwide distillery companies, we have finalized a partnership that will produce and bottle Tover Brands through Nitches. $NICH
— Nitches (@nitchescorp) February 23, 2024
We are happy and confident with the quality of Alamo Distillery Co, in San Antonio, TX.
“Noel Burns, we… pic.twitter.com/8tLLEiyR6s
$NICH - Successful meetings have transpired regarding the Nitches / Tover Project.
Successful meetings have transpired regarding the Nitches / Tover Project. 🥂Our media team is putting together formal updates. 🦾Stay tuned for more refined and updated content between today and tomorrow. Until then, please reference the image attached. 😊 $NICH. #Liquor… pic.twitter.com/h8183KDMEv
— Nitches (@nitchescorp) February 22, 2024
$CBDW Huge bounce and run coming. Hope folks paying attention https://schrts.co/pyBvQjKA
$CAUD Collective Audience Appoints Former Ogilvy and WPP Executive, Christopher Andrews, as COO https://finance.yahoo.com/news/collective-audience-appoints-former-ogilvy-133100672.html
$CAUD are a collaborative collective that believes in the power of collective intelligence, and that we are stronger as a group than as individuals. Our superpower is a relentless drive to innovate. The most fruitful collaborations are those where we walk away having learned something new. We are curious, passionate, proactive problem-solvers. We partner with forward-thinking inspiring brands, agencies, and publishers. https://collectiveaudience.co/about/
$LMLLF News Out! PharmaDrug's Sairiyo Successfully Demonstrates Ability to Manufacture Cepharanthine (PD-001) for Human Clinical Studies
https://finance.yahoo.com/news/pharmadrugs-sairiyo-successfully-demonstrates-ability-132500425.html
$AGBA hearing pending press.
$AGBA hearing pending press.
— SheepWolf 💫 (@realsheepwolf) February 13, 2024
Hope you're in position.
•Shares are tight 55.5M of the 58 O/S are held tightly by Tag Holdings (Richard Tsai) and they have never sold a single share.@agbagroup$SYRA $DBGI $OMH $ARBB $FAMI $BDRX $CHSN $WBUY $ILAG $FAMI $BMR $JBLU $LTRY $BCYC pic.twitter.com/6FVrSDNmg7
$AGBA Group’s commission rates from product providers vary by product type, with insurance products averaging around 50-60% of the Annualized New Premium.
$AGBA Group’s commission rates from product providers vary by product type, with insurance products averaging around 50-60% of the Annualized New Premium. Financial advisors are paid approximately 70% of the commissions AGBA Group receives for typical insurance products, with the… pic.twitter.com/n3dVCylQOX
— AGBA (@agbagroup) January 16, 2024
$CAUD - MEET ADVISOR COLLECTIVE MEMBER DAVID KOHL CEO OF TRUSTX https://reddit.com/r/stockstobuytoday/comments/1apyk2s/caud_meet_advisor_collective_member_david_kohl/
$CAUD Chart setting up for the big move https://schrts.co/rWYNCBqs
$CAUD INTRODUCING BEOP GENERATIVE AI CONTENT THATS REVOLUTIONIZING CONVERSATIONAL ADVERTISING CREATIVITY https://collectiveaudience.co/introducing-beop-generative-ai-content-thats-revolutionizing-conversational-advertising-creativity/
$CBDW is excited to announce the launch of an innovative marketing campaign in collaboration with its latest ISO partner, Cannasite. https://finance.yahoo.com/news/1606-corp-launches-2nd-major-133000255.html
Followers
|
943
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
30343
|
Created
|
06/17/11
|
Type
|
Free
|
Moderator ~ Blue ~ | |||
Assistants doogdilinger balamidas MOMO vantillian CHIEF-RISES-ABOVE |
Posts Today
|
0
|
Posts (Total)
|
30343
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |